par Pantano, Francesco;Iuliani, Michele;Zoccoli, Alice;Fioramonti, Marco ;De Lisi, Delia;Fioroni, Iacopo;Ribelli, Giulia;Santoni, Matteo;Vincenzi, Bruno;Tonini, Giuseppe;Santini, Daniele
Référence Expert opinion on emerging drugs, 20, 4, page (637-651)
Publication Publié, 2015
Référence Expert opinion on emerging drugs, 20, 4, page (637-651)
Publication Publié, 2015
Article révisé par les pairs
Titre: |
|
Auteur: | Pantano, Francesco; Iuliani, Michele; Zoccoli, Alice; Fioramonti, Marco; De Lisi, Delia; Fioroni, Iacopo; Ribelli, Giulia; Santoni, Matteo; Vincenzi, Bruno; Tonini, Giuseppe; Santini, Daniele |
Informations sur la publication: | Expert opinion on emerging drugs, 20, 4, page (637-651) |
Statut de publication: | Publié, 2015 |
Sujet CREF: | Sciences bio-médicales et agricoles |
Mots-clés: | bone metastases |
bone target therapy | |
osteoblast | |
osteoclast | |
MeSH keywords: | Animals |
Antineoplastic Agents -- pharmacology -- therapeutic use | |
Bone Density Conservation Agents -- pharmacology -- therapeutic use | |
Bone Neoplasms -- drug therapy -- pathology -- secondary | |
Denosumab -- pharmacology -- therapeutic use | |
Diphosphonates -- pharmacology -- therapeutic use | |
Drug Design | |
Humans | |
Molecular Targeted Therapy | |
Survival Rate | |
Tumor Microenvironment | |
Langue: | Anglais |
Identificateurs: | urn:issn:1472-8214 |
info:doi/10.1517/14728214.2015.1062876 | |
info:pmid/26113304 |